Site Search
Professionals 871 results
Capabilities 83 results
Practice Area
Today’s legal and regulatory landscape is more fraught with risk than ever before. To survive—and thrive—in this challenging environment, sophisticated companies must have robust, proactive, and effective compliance programs in place.
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes.
Industry
Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry.
Experience 59 results
Experience
|April 1, 2025
Experience
|March 18, 2025
Insights & News 3,556 results
Recognitions
|June 26, 2025
|1 Min Read
Winston Partners Included on Forbes’ Inaugural List of America's Best-In-State Lawyers
Winston & Strawn’s Financial Services Industry Group Co-Chair Kobi Kennedy Brinson and Digital Assets Group Co-Chair Daniel Stabile were included on Forbes’ inaugural list of America's Best-In-State Lawyers. This list identifies “the finest in the profession: lawyers with impressive track records in their specialties, leaders in their fields and attorneys most respected by peers and clients.” Kobi was the only attorney featured in the “Government Regulatory” category and Daniel was likewise the only attorney highlighted for “Blockchain & Digital Assets.”
Webinar
|June 25, 2025
What’s Going on in the World of Enforcement?
In this webinar, our attorneys discussed the latest developments at the Consumer Financial Protection Bureau (CFPB), the Department of Justice (DOJ), and the Securities and Exchange Commission (SEC), and what these changes may mean for the financial services industry.
Client Alert
|June 24, 2025
|10+ Min Read
Receiving notice of an SEC investigation is not only a stressful moment for any public company—it is one that requires prompt and diligent action. This guide provides an overview of the stages of an SEC investigation and some key considerations along the way, including best practices to avoid regulatory scrutiny in the first instance.
Other Results 77 results
Site Content
Law Glossary
What Exclusivity Periods Are Associated with Biosimilars?
An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)